Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bavarian Nordic A/S
(OP:
BVNKF
)
29.50
-0.50 (-1.67%)
Streaming Delayed Price
Updated: 3:58 PM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,420
Open
29.50
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
30.00
Today's Range
29.50 - 30.90
52wk Range
20.71 - 37.60
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat
↗
September 17, 2024
The UK government has purchased 150,000 mpox vaccine doses from Bavarian Nordic, enhancing its response to clade I mpox, while partnering with WHO and UNICEF.
Via
Benzinga
Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows
↗
September 06, 2024
Moderna is conducting a Phase 1/2 trial of mRNA-1769, a potential mpox vaccine for adults. Early research shows it may outperform Bavarian Nordic's Jynneos in reducing severe disease in monkeys.
Via
Benzinga
Performance
YTD
+9.2%
+9.2%
1 Month
+0.8%
+0.8%
3 Month
-18.1%
-18.1%
6 Month
+9.8%
+9.8%
1 Year
+10.6%
+10.6%
More News
Read More
Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic
↗
September 06, 2024
Via
Benzinga
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
↗
August 26, 2024
Via
Benzinga
Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency
↗
August 16, 2024
Via
Benzinga
Bavarian Nordic Recruits US Firm For Packaging Services For Its Monkeypox Vaccine
↗
August 19, 2022
Via
Benzinga
Bavarian Nordic's Monkeypox Vaccine Gets Thumbs Up From EU Regulator
↗
July 22, 2022
Via
Benzinga
Monkeypox Vaccine Maker Bavarian Nordic Bets $380M On Emergent Bio's Travel Vaccines
↗
February 15, 2023
Via
Benzinga
West Africa-Based Studies Show JNJ, Merck's Ebola Vaccines Provide Lasting Antibodies
↗
December 15, 2022
Via
Benzinga
Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa
↗
November 03, 2022
Via
Benzinga
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
↗
September 02, 2022
Via
Benzinga
Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed
↗
August 26, 2022
Via
Benzinga
SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report
↗
August 25, 2022
Via
Benzinga
Bavarian Nordic Making All Efforts To Stretch Capacity To Boost Monkeypox Vaccine Supplies
↗
August 24, 2022
Via
Benzinga
Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch
↗
August 23, 2022
Via
Benzinga
Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test
↗
August 19, 2022
Via
Benzinga
Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment
↗
August 18, 2022
Via
Benzinga
WeTrade Shares Soar On Collaboration Over Exclusive COVID-19 Omicron Disinfectant
↗
August 18, 2022
Via
Benzinga
A Biopharma Working On Malaria, Norovirus Vaccines Threw It's Hat In The Monkeypox Ring
↗
August 17, 2022
Via
Benzinga
Benzinga Before The Bell: More Amazon Workers Join Union Over Pay and Work Conditions, UK Inflation Highest In 40 Years, Sole Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand And Other Top Financial Stories Wednesday, August 17
↗
August 17, 2022
Via
Benzinga
The Only Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand
↗
August 17, 2022
Via
Benzinga
Bavarian Nordic's Monkeypox Vaccine Scores EU Approval As WHO Declares Global Health Emergency
↗
July 25, 2022
Via
Benzinga
The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings
↗
July 19, 2022
Via
Benzinga
Bavarian Nordic Inks Multiple Supply Pact For Its Monkey pox Vaccine, Updates FY22 Guidance
↗
July 18, 2022
Via
Benzinga
Bavarian Nordic Launches COVID-19 Booster Study To Compare Against Pfizer/BioNTech Shot
↗
June 16, 2022
Via
Benzinga
Frequently Asked Questions
Is Bavarian Nordic A/S publicly traded?
Yes, Bavarian Nordic A/S is publicly traded.
What exchange does Bavarian Nordic A/S trade on?
Bavarian Nordic A/S trades on the OTC Traded
What is the ticker symbol for Bavarian Nordic A/S?
The ticker symbol for Bavarian Nordic A/S is BVNKF on the OTC Traded
What is the current price of Bavarian Nordic A/S?
The current price of Bavarian Nordic A/S is 29.50
When was Bavarian Nordic A/S last traded?
The last trade of Bavarian Nordic A/S was at 12/31/25 03:58 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.